G. Dranitsaris

TL;DR: A systematic review and meta-analysis conducted to test the hypothesis that oncology health care workers are at an increased risk of cancer, reproductive complications and acute toxic events identified a small incremental risk for spontaneous abortions in female staff working with cytotoxic agents.

TL;DR: Severe diarrhea requiring hospital admission is a costly and potentially fatal complication of chemotherapy in colorectal cancer, and the identification of predictive factors and the implementation of prophylactic measures could reduce the morbidity and mortality associated with diarrhea.

TL;DR: A small number of cancer patients receiving certain chemotherapy drugs are at an increased risk for developing secondary malignancies and these patients should be aware of the risks to their health and be prepared for adverse events.

TL;DR: Grade III/IV diarrhea is a debilitating and costly complication of chemotherapy in colorectal cancer and effective interventions that prevent the development of severe diarrhea need to be identified to save health-care costs and reduce patient morbidity.

TL;DR: The current efficacy measures used in recent bisphosphonate trials are reviewed and their benefits and limitations are discussed and the role of bone biomarkers and their potential use in monitoring treatment response are explored.